Cancer survival rate grows & so does number of new cases

by , under Big Pharma, Contemporary Cancer Topics, The Cancer Industry

Something is definitely amiss here. The statistics show that the cancer survival rate is increasing. Although I doubt it, we will just give them the benefit of the doubt here.

The really disturbing thing is that the number of new cases of cancer are virtually exploding. Something is not right with the current paradigm if cancer rates are steadily increasing.

Evidently, the Medical Establishment either doesn’t really understand what causes cancer and why cancer is becoming a virtual epidemic, or they are conditioned to keep doing the same thing while expecting a different result. If they can’t figure out what’s going on, and they are supposed to be the experts, that is a bad sign.

I suspect that the allowed research avenues are all akin to trying to crawl around the world, instead of taking the jet. It appears that they are purposely taking the slow path so that they can keep up all this furious, but meaningless research with a dismal expenditure to reward ratio. The bottom line is the results. Are we getting more effective treatments for cancer, or are they just making huge profits while making infinitesimal progress so that they can just keep milking the Big Pharma drug cash cow?

They claim that they have no cures, but they sure do charge like they are cures! Some of these cancer drugs can cost upwards of $10,000 per month. That’s some serious money.

Learn how to beat cancer after your doctor gives up on you…


As cancer survival rate grows, so does number of new cases (emphasis added)

Even as cancer treatment improves and survival rates go up, so too does the number of people afflicted with the deadly disease, experts said ahead of World Cancer Day.

The 14 million new cancer cases worldwide recorded in 2012 will balloon to 24 million within two decades, outstripping the increase in global population, according to the World Health Organization (WHO).

Smashcancer: So they’re saying here that the cancer rates are growing faster than the population. That sounds like an epidemic to me. If they wanted to do the most advanced thing, they’d be focusing on prevention, not on awareness. I think that most people are already aware about cancer.

All forms of cancer combined claimed 8.8 million lives in 2015, making it the second leading cause of death after heart disease.

“We know how to help avoid it, and to detect it. We’re getting better at treating it. But overall, we’re not making real headway in the fight against cancer,” said Christophe Leroux, head of communications for France’s League Against Cancer.

Smashcancer: They’re admitting that they’re not really making any meaningful progress in fighting cancer. The stats may say they’re getting better, but for most people, a cancer diagnosis is reason to be very scared and nervous.

Several factors account for the disease’s growing prevalence.

One is aging populations, especially in developed nations and China, where a one-child-per-family policy in force for more than 30 years created a top-heavy age pyramid.

Cancer risk increases with age.

There is also a long list of lifestyle habits linked to cancer, with tobacco consumption at the top. Other risk factors—all of them increasing—include eating poorly, lack of exercise, drinking alcohol, and obesity.

Cancer-causing infections such as hepatitis and the human papilloma virus (HPV) account for a quarter of cancer cases, mostly in low- and middle-income countries.

Another risk is exposure to carcinogenic industrial pollutants, including asbestos, organic pollutants such as dioxins, heavy metals and small air particles that lodge in the lungs.

Smashcancer: None of the industries or the government, especially in the United States, are seriously working to remove or meaningfully reduce their emissions of industrial pollutants, organic pollutants and/or heavy metals. Even with the EPA regulations, a lot of industrial waste is being discharged into the environment. It ends up inside of us, causing disease.

Unequal access

Despite the growing challenges, five-year survival rates for most cancers have improved—sometimes significantly—since 2000, according to a study published last week in medical journal The Lancet that reviewed 37.5 million cancer cases between 2000 and 2014.

But large disparities between societies remain, depending on level of development and differences in health case systems.

For children with brain tumours, for example, five-year survival has improved across the board from 54 percent for the period 2000-2004, to more than 60 percent for 2010-2014. In the United States, Denmark, Sweden and Slovakia, the survival rate progressed to 80 percent or better.

In Mexico and Brazil, however, less than 40 percent of children diagnosed with brain tumours survived in the 2010-2014 period.

Breast cancer rates also improved across the board, even as disparities remained.

Five-year survival rates for 2010-2014 in the US and Australia were 90 percent. In western and eastern Europe, the rate improved to 85 and 71 percent, respectively.

“If we want fewer deaths from cancer, there are two ways: first, better prevention, and second, improving outcomes,” co-author Michel Coleman, an epidemiologist a researcher at the London School of Hygiene and Tropical Medicine, told AFP.

Treatment costs $300 bn

Cancer is also a costly disease, both for health care systems of for society at large.

Globally, the total annual economic cost of cancer exceeds a trillion dollars, according the WHO.

Smashcancer: A trillion dollars is a lot of incentive to stay with the status quo. Anybody who thinks that this isn’t a factor in how the Medical Establishment approaches cancer is extremely naive.

Much of that burden falls on developing nations.

Lost productivity due to premature cancer deaths in five emerging economies—India, China, Brazil, South Africa and Russia—was more than $46 billion (37 billion euros) in 2012, according a study released this week by the UN’s International Agency for Research on Cancer.

Caring for cancer patients is also expensive.

“It seems plausible that the global cost of cancer treatment and care in 2017 must already be substantially higher than $300 billion,” the authors of the Lancet study concluded.

Inevitably, less money also means higher death rates.

“A lack of access to treatment is leading to premature deaths which could have otherwise been prevented,” said Sanchia Aranda, head of Cancer Council Australia.

“Low- and middle-income countries face the brunt as millions of people die prematurely from cancer every year as a result of inequities in access to diagnosis.”

Leave a Reply